Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page
- Check7 days agoChange DetectedA new revision entry, v3.6.3, was added to the study's record history. The previous revision, v3.6.2, was removed from the current history view.SummaryDifference0.1%

- Check14 days agoChange DetectedThe Record History shows a new Revision: v3.6.2 entry replacing v3.6.0, representing a new software release for the study record interface.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe Version History UI now displays 'Last verified' and 'Last known status was' and adds a 'Revision: v3.6.0' tag, replacing the previous 'Verified', 'Last known status was:', and 'Revision: v3.5.5' indicators. This change updates how revision metadata is presented without modifying the underlying study data.SummaryDifference2%

- Check36 days agoChange DetectedA new software revision entry (v3.5.5) was added to the Record History. The previous revision (v3.5.4) was removed, reflecting a minor platform update.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 was removed, indicating a platform upgrade. This change does not modify the trial record content or data shown on the page.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.5.3 was added to the Record History, replacing the prior Revision: v3.5.2. This reflects a minor site update to the page history.SummaryDifference0.1%

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.